Lange JA

No ORCID on file · 1 paper in corpus
article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.05.049

ObjectiveDienogest (DNG) 2 mg (Visanne) was launched for endometriosis treatment in Europe in 2010. The Visanne Post-approval Observational Study (VIPOS) was designed to assess the safety of DNG 2 mg/day compared to other hormonal endometri…